Comparison of TAP Bock vs QL Block in Varicocele Surgery
The Comparison of TAP Block and QL Block on Postoperative Analgesic Consumption and Patient Satisfaction After Varicocele Surgery
1 other identifier
interventional
75
1 country
2
Brief Summary
In this study we aim to compare the effect of TAP block and QL block on postoperative analgesia, analgesic consumption , side effects and patient satisfaction after varicocelec surgery. 75 patients will be randomized into 3 groups:TAP Group (Group T) n = 25, QL Group (Group Q) n = 25, Control Group (Group K) n = 25 All patients will be operated on with spinal anesthesia. TAP and QL blocks will be performed after completion of the surgeries. In the postoperative care unit, an iv patient-controlled analgesia protocol with tramadol will be started. Patients in all three groups will be assessed with a resting and cough VAS (visual analog scale) at postoperative 2,4,6,12,18 and 24 hours and values will be recorded. The amount of analgesic consumption and the first analgesic request times will be recorded. Post-operative QUIPS: Quality Improvement in Postoperative Pain Management questionnaire will be applied, side effects such as nausea-vomiting, drowsiness will be noted. In addition, patient satisfaction will be assessed with these methods as bad, medium, good, and very good.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Dec 2018
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 25, 2018
CompletedFirst Submitted
Initial submission to the registry
December 26, 2018
CompletedFirst Posted
Study publicly available on registry
January 4, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 25, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
June 25, 2020
CompletedNovember 18, 2019
November 1, 2019
1.3 years
December 26, 2018
November 15, 2019
Conditions
Outcome Measures
Primary Outcomes (1)
Postoperative analgesic consumption
The amount of analgesic agent consumption in the postoperative 24 hours with iv PCA will be recorded.
postoperative 24 hours
Secondary Outcomes (1)
Patient satisfacion
postoperative 24 hours
Study Arms (3)
Group T
ACTIVE COMPARATORAt the end of the surgery USG guided TAP block will be performed with 20 mL of 0.25% isobaric bupivacaine.
Group Q
ACTIVE COMPARATORAt the end of the surgery USG guided QL block will be performed with 20 mL of 0.25% isobaric bupivacaine.
Group C
NO INTERVENTIONIn this group no intervention will be performed after the end of operation.
Interventions
Eligibility Criteria
You may qualify if:
- ASA 1-2
- Patients undergoing varicocele surgery
You may not qualify if:
- Patient refusal
- Coagulation abnormality.
- contraindication for spinal anesthesia
- Failed block
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Ömer Faruk Boranlead
Study Sites (2)
Kahramanmaras Sutcu Imam University
Kahramanmaraş, 46000, Turkey (Türkiye)
Kahramanmaraş Sütçü Imam Üniversity
Kahramanmaraş, 46000, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Ömer F Boran
Bay
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
December 26, 2018
First Posted
January 4, 2019
Study Start
December 25, 2018
Primary Completion
April 25, 2020
Study Completion
June 25, 2020
Last Updated
November 18, 2019
Record last verified: 2019-11
Data Sharing
- IPD Sharing
- Will not share